🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Urologist Michael Poch, MD (@Michael_Poch) shares insights on an innovative trial exploring TIL therapy for bladder cancer. This study is pushing boundaries and applying #TILtherapy to a new type of cancer. Read more: bit.ly/3Xfq3pA #CancerResearch

While at #ASTRO24, Anupam Rishi, MD (Anupam Rishi) joined us to discuss the DRIVE study, a multi-institutional collaborative research initiative focused on vulvar cancer patients treated with high-dose IMRT. Learn more ➡️ bit.ly/4dmsOvf #MoffittASTRO24 ASTRO

Just in 👉 Journal of Clinical Oncology Benefit of Whole-Pelvis Radiation ☢️ for Patients With #MIBC ascopubs.org/doi/10.1200/JC… 👇👇👇TWEETORIAL 👇👇👇

Patient perspectives on #BladderCancer: Balancing treatment options and shared decision-making. Roger Li Moffitt Cancer Center joins Ashish M. Kamat, MD, MBBS MD Anderson Cancer Center discussing findings from a patient panel at #BCANTT24 on BCG-unresponsive and #MIBC > bit.ly/3MZDndb Bladder Cancer Advocacy Network

🚨Out now Nature Medicine🚨 Final results from #CORE2 combining IVe Creto+Nivo in cis-ineligible MIBC pts nature.com/articles/s4159… No DLTs pCR = 42.1% pCR assoc with baseline free E2F activity, TMB Increased T cell infiltration Formation of TLS assoc with pCR Moffitt Cancer Center

Great work led by MoffittRadOnc star resident Vaseem Khatri assessing ADC T-DXd with SRS QuadShot News PDBrown Moffitt Cancer Center

‼️🚨The best current evidence on the role of HPV in Penile Cancer: A Meta-Analysis by our group Moffitt Cancer Center Philippe spiess Anna Giuliano Curtis Pettaway, MD Majd Al Assaad, MD ACS National HPV Vaccination Roundtable Houssein Safa, MD NCCC HPV Action Network Massachusetts HPV Coalition HPV-cancer.org doi.org/10.6004/jnccn.…

Congratulations to Moffitt's Peter Johnstone, MD, for being awarded the Amer. Radium Society Gold Medal this year! 🏅 This honor recognizes his outstanding contributions to oncology and exceptional service to the American Radium Society. Congratulations to Dr. Johnstone on an exciting

hot off the press - our Moffitt Cancer Center #multiD approach to #PAE in the setting of prostate cancer!! let’s go! 💪🏾💪🏾 Kosj Yamoah MD, PhD G. Daniel Grass MD, PhD Julio Pow-Sang MoffittRadOnc Anupam Rishi #irad

Results from our phase II trial of brain MRI surveillance in stage IV breast cancer now out in SNO academic.oup.com/neuro-oncology… By 6 months, about 25% of patients developed brain mets regardless of subtype OncoAlert Thank you Florida Breast Cancer Foundation for the support!

Excellent talk by Kenneth Gage MD, PhD dissecting the radiographic implications of PSMA-PET directed treatment decision making for the management of oligometastatic prostate cancer at GU ASCO 2025 in San Francisco Moffitt Cancer Center MoffittRadOnc

You are advancing the field of penile cancer patients around the globe through your pioneering research Jad. Could not be more honored and privileged to work together. Truly one of the greatest joys in my career! 👏👏👏

1/ Excited to share our new paper in npj Digital Medicine. We worked with Fei Wang to develop a cutting-edge AI model 🖥️ that predicts response to neoadjuvant chemotherapy 💉 in patients with muscle-invasive #bladdercancer in the S1314 randomized clinical trial

Received this letter today. Extremely honored to join this laser-focused group of clinicians/scientists/advocates that work tirelessly to eradicate #bladdercancer. Much to learn & much to do for our patients. Thank you IBCG for the opportunity.

Using ROICellTrack on urothelial carcinoma, we identified distinct cancer-immune cell mixtures linked to transcriptomic & morphological signatures. Check out our recent paper with Xiaofei (Sophia) Song and Roger Li. academic.oup.com/bioinformatics… #SpatialTranscriptomics

Big news from #SperosFlorida! Moffitt’s proton therapy system has arrived! This major milestone brings us one step closer to offering highly targeted cancer treatment to patients.

Bladder preservation in muscle-invasive bladder cancer (MIBC) is evidence-based, patient-centered, and underutilized The latest IBCG consensus in European Urology offers global expert recommendations on when, how, and for whom bladder-sparing strategies are appropriate

Honored to be recognized by the SUO with this prestigious award. Humbled to be amongst my esteemed predecessors. Much more to do in #bladdercancer Society of Urologic Oncology Amer. Urol. Assn. Bladder Cancer Advocacy Network IBCG Moffitt Urologic Oncology Fellowship Moffitt Cancer Center

Excited to have been part of this landmark study of metastatic prostate cancer in U.S. Veterans! These findings affirm that precision oncology can be a powerful tool for advancing equity in cancer care. #CancerResearch #ProstateCancer